TABLE 1.
Descriptive characteristics for the n = 123 postmenopausal women of our study.
| Mean ± SD or Frequency (%) | IQR | |
|---|---|---|
| Anthropometric/demographic parameters | ||
| Age (years) | 55.5 ± 5.8 | 52.0–58.0 |
| YSM (years) | 7.58 ± 5.9 | 3.0–10.0 |
| BMI (kg/m2) | 25.9 ± 4.3 | 23.0–28.4 |
| Overweight—obesity (%) | 49.7% (79/159) | |
| SBP (mmHg) | 119.3 ± 17.4 | 106.0–130.0 |
| DBP (mmHg) | 74.2 ± 9.1 | 67.8–81.0 |
| Current smoking (%) | 29.6% (47/159) | |
| Biochemical parameters | ||
| Cholesterol (mg/dl) | 230.4 ± 39.1 | 209.0–256.0 |
| HDL-C (mg/dl) | 62.0 ± 17.3 | 50.0–72.8 |
| Triglycerides (mg/dl) | 90.9 ± 39.9 | 66.0–102.0 |
| LDL-C (mg/dl) | 142.4 ± 36.7 | 114.5–168.0 |
| Glucose (mg/dl) | 92.1 ± 8.9 | 86.0–97.0 |
| Insulin (μIU/ml) | 7.1 ± 4.5 | 4.3–8.5 |
| HOMA-IR | 1.7 ± 1.2 | 0.9–1.9 |
| C-reactive protein (mg/dl) | 0.4 ± 0.7 | 0.1–0.3 |
| Hormonal parameters | ||
| FSH (mIU/ml) | 76.4 ± 30.6 | 53.6–98.6 |
| LH (mIU/ml) | 37.7 ± 19.3 | 25.3–46.2 |
| Testosterone (ng/dl) | 0.4 ± 0.3 | 0.3–0.5 |
| SHBG (nmol/L) | 66.3 ± 28.4 | 45.1–86.3 |
| FAI | 2.5 ± 1.8 | 1.3–3.2 |
| DHEAS (ng/dl) | 345.2 ± 80.8 | 85.0–640.0 |
| Endothelial function | ||
| Flow mediated dilation (%) | 5.4 ± 2.7 | 3.3–6.8 |
YSM, years since menopause; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; FSH, follicular stimulating hormone; LH, luteinizing hormone; SHBG, sex hormone binding globulin; FAI, free androgen index; SD, standard deviation; IQR, interquartile range.